News | January 26, 2022
Torrent Pharmaceuticals consolidated PAT at Rs 249 cr
Torrent Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
Torrent Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
DCGI approved the drug based on the review of clinical data
Torrent Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
The company posted net profit of Rs.321 crores for the period ended June 30, 2020.
The agreement will help ensure wider reach and access to patients in India
The quarter included three IPOs worth US$ 428 million and one Qualified Institutional Placement (QIP) worth US$ 88 million
Positive volume growth was observed in key therapies such as respiratory (13.2% yoy), anti-neoplastics (12.1% yoy) and cardiac (4.8% yoy) during September 2025
He has previously served in pivotal HR leadership roles at RPG Life Sciences, Akumentis Healthcare, and Wockhardt
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Subscribe To Our Newsletter & Stay Updated
